Trends and correlation of antibacterial usage and bacterial resistance: time series analysis for antibacterial stewardship in a Chinese teaching hospital (2009–2013)

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 34, Issue 4, 2015, Pages 795-803

  Zou, Y M ^a,b   Ma, Y ^a   Liu, J H ^a   Shi, J ^a   Fan, T ^a   Shan, Y Y ^a   Yao, H P ^a   Dong, Y L ^a  

^a THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

^b XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; IMIPENEM; MEROPENEM; ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ARTICLE; CHINA; ESCHERICHIA COLI; HUMAN; KLEBSIELLA PNEUMONIAE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; TEACHING HOSPITAL; TERTIARY CARE CENTER; TIME SERIES ANALYSIS; BACTERIAL INFECTIONS; BACTERIUM; DRUG EFFECTS; DRUG UTILIZATION; HEALTH CARE POLICY; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; POLICY; PRESCRIPTION; PREVALENCE; PROCEDURES; STANDARDS; TIME;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; CHINA; DRUG PRESCRIPTIONS; DRUG RESISTANCE, BACTERIAL; DRUG THERAPY; DRUG UTILIZATION; HEALTH POLICY; HOSPITALS, TEACHING; HUMANS; MICROBIAL SENSITIVITY TESTS; ORGANIZATIONAL POLICY; PREVALENCE; TERTIARY CARE CENTERS; TIME FACTORS;

EID: 84925519908     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-014-2293-6     Document Type: Article

References (30)

1. Wise R, Hart T, Cars O, Streulens M, Helmuth R, Huovinen P, Sprenger M (1998) Antimicrobial resistance. Is a major threat to public health. BMJ 317:609–610
2. Levy SB, Marshall B (2004) Antibacterial resistance worldwide: causes, challenges and responses. Nat Med 10:S122–129
3. Roberts RR, Hota B, Ahmad I, Scott RD 2nd, Foster SD, Abbasi F, Schabowski S, Kampe LM, Ciavarella GG, Supino M, Naples J, Cordell R, Levy SB, Weinstein RA (2009) Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: Implications for antibiotic stewardship. Clin Infect Dis 49:1175–1184
4. Bush K, Courvalin P, Dantas G, Davies J, Eisenstein B, Huovinen P, Jacoby GA, Kishony R, Kreiswirth BN, Kutter E, Lerner SA, Levy S, Lewis K, Lomovskaya O, Miller JH, Mobashery S, Piddock LJ, Projan S, Thomas CM, Tomasz A, Tulkens PM, Walsh TR, Watson JD, Witkowski J, Witte W, Wright G, Yeh P, Zgurskaya HI (2011) Tackling antibiotic resistance. Nat Rev Microbiol 12:894–896
5. Sousa D, Castelo-Corral L, Gutiérrez-Urbón JM, Molina F, López-Calviño B, Bou G, Llinares P (2013) Impact of ertapenem use on Pseudomonas aeruginosa and Acinetobacter baumannii imipenem susceptibility rates: collateral damage or positive effect on hospital ecology? J Antimicrob Chemother 68:1917–1925
6. Pires dos Santos R, Jacoby T, Pires Machado D, Lisboa T, Gastal SL, Nagel FM, Kuplich NM, Konkewicz L, Gorniak Lovatto C, Pires MR, Goldani LZ (2011) Hand hygiene, and not ertapenem use, contributed to reduction of carbapenem-resistant Pseudomonas aeruginosa rates. Infect Control Hosp Epidemiol 32:584–590
7. Dellit TH, Owens RC, McGowan JE Jr, Gerding DN, Weinstein RA, Burke JP, Huskins WC, Paterson DL, Fishman NO, Carpenter CF, Brennan PJ, Billeter M, Hooton TM; Infectious Diseases Society of America; Society for Healthcare Epidemiology of America (2007) Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 44:159–177
8. Mölstad S, Erntell M, Hanberger H, Melander E, Norman C, Skoog G, Lundborg CS, Söderström A, Torell E, Cars O (2008) Sustained reduction of antibiotic use and low bacterial resistance: 10-year follow-up of the Swedish Strama programme. Lancet Infect Dis 8:125–132
9. Bager F (2000) DANMAP: monitoring antimicrobial resistance in Denmark. Int J Antimicrob Agents 14:271–274
10. Mölstad S, Cars O (1999) Major change in the use of antibiotics following a national programme: Swedish Strategic Programme for the Rational Use of Antimicrobial Agents and Surveillance of Resistance (STRAMA). Scand J Infect Dis 31:191–195
11. Fridkin SK, Steward CD, Edwards JR, Pryor ER, McGowan JE Jr, Archibald LK, Gaynes RP, Tenover FC (1999) Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals. Clin Infect Dis 29:245–52
12. Martínez JA, Delgado E, Martí S, Marco F, Vila J, Mensa J, Torres A, Codina C, Trilla A, Soriano A, Alquezar A, Castro P, Nicolás JM (2009) Influence of antipseudomonal agents on Pseudomonas aeruginosa colonization and acquisition of resistance in critically ill medical patients. Intensive Care Med 35:439–447
13. Nouér SA, Nucci M, De-Oliveira MP, Pellegrino FL, Moreira BM (2005) Risk factors for acquisition of multidrug-resistant Pseudomonas aeruginosa producing SPM metallo-beta-lactamase. Antimicrob Agents Chemother 49:3663–3667
14. Ozkurt Z, Ertek M, Erol S, Altoparlak U, Akcay MN (2005) The risk factors for acquisition of imipenem-resistant Pseudomonas aeruginosa in the burn unit. Burns 31:870–873
15. Su CH, Wang JT, Hsiung CA, Chien LJ, Chi CL, Yu HT, Chang FY, Chang SC (2012) Increase of carbapenem-resistant Acinetobacter baumannii infection in acute care hospitals in Taiwan: association with hospital antimicrobial usage. PLoS One 7:e37788
16. Lipsitch M, Samore MH (2002) Antimicrobial use and antimicrobial resistance: a population perspective. Emerg Infect Dis 8:347–354
17. Iosifidis E, Antachopoulos C, Tsivitanidou M, Katragkou A, Farmaki E, Tsiakou M, Kyriazi T, Sofianou D, Roilides E (2008) Differential correlation between rates of antimicrobial drug consumption and prevalence of antimicrobial resistance in a tertiary care hospital in Greece. Infect Control Hosp Epidemiol 29:615–622
18. Messadi AA, Lamia T, Kamel B, Salima O, Monia M, Saida BR (2008) Association between antibiotic use and changes in susceptibility patterns of Pseudomonas aeruginosa in an intensive care burn unit: a 5-year study, 2000–2004. Burns 34:1098–1102
19. Lepper PM, Grusa E, Reichl H, Högel J, Trautmann M (2002) Consumption of imipenem correlates with beta-lactam resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 46:2920–2925
20. Tacconelli E, De Angelis G, Cataldo MA, Mantengoli E, Spanu T, Pan A, Corti G, Radice A, Stolzuoli L, Antinori S, Paradisi F, Carosi G, Bernabei R, Antonelli M, Fadda G, Rossolini GM, Cauda R (2009) Antibiotic usage and risk of colonization and infection with antibiotic-resistant bacteria: a hospital population-based study. Antimicrob Agents Chemother 53:4264–4269
21. Tacconelli E, Venkataraman L, De Girolami PC, Dagata EM (2004) Methicillin-resistant Staphylococcus aureus bacteraemia diagnosed at hospital admission: distinguishing between community-acquired versus healthcare-associated strains. J Antimicrob Chemother 53:474–479
22. Livermore DM (2004) Can better prescribing turn the tide of resistance? Nat Rev Microbiol 2:73–78
23. Cosby JL, Francis N, Butler CC (2007) The role of evidence in the decline of antibiotic use for common respiratory infections in primary care. Lancet Infect Dis 7:749–756
24. Strateva T, Yordanov D (2009) Pseudomonas aeruginosa—a phenomenon of bacterial resistance. J Med Microbiol 58:1133–1148
25. Mesaros N, Nordmann P, Plésiat P, Roussel-Delvallez M, Van Eldere J, Glupczynski Y, Van Laethem Y, Jacobs F, Lebecque P, Malfroot A, Tulkens PM, Van Bambeke F (2007) Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium. Clin Microbiol Infect 13:560–578
26. Rice LB (2006) Challenges in identifying new antimicrobial agents effective for treating infections with Acinetobacter baumannii and Pseudomonas aeruginosa. Clin Infect Dis 43:S100–S105
27. Baumgart AM, Molinari MA, Silveira AC (2010) Prevalence of carbapenem resistant Pseudomonas aeruginosa and Acinetobacter baumannii in high complexity hospital. Braz J Infect Dis 14:433–436
28. Scheffer MC, Gales AC, Barth AL, Carmo Filho JR, Dalla-Costa LM (2010) Carbapenem-resistant Pseudomonas aeruginosa: clonal spread in southern Brazil and in the state of Goiás. Braz J Infect Dis 14:508–509
29. Mutnick AH, Rhomberg PR, Sader HS, Jones RN (2004) Antimicrobial usage and resistance trend relationships from the MYSTIC Programme in North America (1999–2001). J Antimicrob Chemother 53:290–296
30. Harbarth S, Harris AD, Carmeli Y, Samore MH (2001) Parallel analysis of individual and aggregated data on antibiotic exposure and resistance in gram-negative bacilli. Clin Infect Dis 33:1462–1468